Our immunology research spans the gamut from basic molecular studies through to clinical trials and new patient treatments.
We are particularly strong in the areas of conventional and unconventional T-cell immunity, cancer immunotherapy, autoimmune disease, homing and trafficking of immune cells and the structure biology of antigen receptors and the ligands they recognise.
Area of interest
T-cell ligands and the receptors that recognise them during infection, autoimmune disease, organ transplant and cancer immunotherapy.
Principal members of staff
|Name||Area of interest|
|Professor Jamie Rossjohn||Structure and biophysics of innate and adaptive immune recognition|
|Dr Pierre Rizkallah||Protein structure biology|
|Professor Colin Dayan||Autoimmune disease|
|Professor Susan Wong||Type 1 diabetes|
|Professor Bernhard Moser||Immune cell migration|
|Professor Andrew Godkin||MHC class II and cancer immunotherapy|
|Professor Awen Gallimore||Immune tolerance and cancer immunotherapy|
|Professor Matthias Eberl||Unconventional T-cells|
|Professor Ann Ager||Lymphocyte homing|
Our research creates benefits across health, society and the economy.